During last week’s Q3 earnings call, a Wall Street analyst asked Chromadex CEO Rob Fried to compare the bodily impact of the new Niagen+ IV to NAD+ boosting supplement Niagen (Nicotinamide Riboside “NR” (FAQs) (Anecdotes)). Here’s the question followed by CEO Fried’s response:

Sean McGowan (Wall Street Analyst)

“…when you talk about the dosage on Niagen Plus (NR IV) at 500 milligrams, how would 500 milligrams in that form compare to the dosages that are in the Tru Niagen capsules in terms of the impact on the body?

Chromadex CEO Rob Fried

“Well, our scientists are still studying over a few months what the long-term differential is.

So I’m going to wait a quarter before I give data on that comparison.

But what you have to understand is that when you swallow the capsules, it goes through the gut and then it goes to the liver, and it delivers a relatively small amount of pure NR into the bloodstream, which we have proven gets taken up into the cells and crosses the blood-brain barrier, and gets into the organs, and is effective — and from all the studies we published you see has therapeutic and prophylactic benefits.

But when you get it directly into the bloodstream, pure pharmaceutical-grade sterilized Niagen, it has many times the potency of that dose.

And we’ve seen that in the one published study that we’ve put out there comparing Niagen IV to NAD IV, extremely high levels of NAD in the bloodstream within 2 hours of Niagen IV.

But we don’t yet have data to share comparing Niagen IV to Tru Niagen capsules.

Related Articles: